Asian press release distribution

Press Releases for Friday, March 4, 2022

	Altamira Therapeutics and Nuance Pharma Enter Into Exclusive Licensing and Distribution Agreement for Bentrio in China and Additional Asian Markets 22:30 HKT/SGT

	iLearn Announces the Release of EggHeads: An Edutainment Platform for Web3 or Web2 Companies Where Virtually Any Prize Is Possible 19:00 HKT/SGT

	Toyota: Statement Concerning the Fuel Efficiency Performance of Our Coaster Small Bus 17:17 HKT/SGT

	MHI Announces Changes in Executive-level Personnel 16:33 HKT/SGT

	MHI Group Presents "Best Innovation 2021" Awards for Activities that Contribute to Mitigating Impacts on the Global Environment 16:12 HKT/SGT

	Sony and Honda Sign Memorandum of Understanding for Strategic Alliance in Mobility Field 14:44 HKT/SGT

	Bosch, Mitsubishi Corporation and BPSE Team Up to Empower Electrification of Commercial Operating Fleet by Providing Battery Insight 14:37 HKT/SGT

	Honda to Issue U.S. Dollar-Denominated Green Bonds (Unsecured Straight Bonds) to Accelerate its Environmental Initiatives 12:51 HKT/SGT

	Eisai Initiates Submission of Application Data Under the Prior Assessment Consultation System in Japan with the Aim of Obtaining Early Approval for Investigational Anti-Amyloid Beta Protofibril Antibody Lecanemab 10:05 HKT/SGT

	Mitsubishi Motors Introduces the All-New Outlander PHEV Model in New Zealand 09:36 HKT/SGT

	Quantum Solutions Explores Strategic Partnership with Duke New Energy Vehicle Co. for R&D, Design and Manufacturing of EVs 09:30 HKT/SGT

	BayWa r.e. Reaffirms Continued Commitment to the Community of Lang Son Province with Improved Sanitation Facilities for Elementary Schools 09:00 HKT/SGT

	ServiceNow Customers Empowered to Drive Better Risk-Informed Decisions across the Enterprise with the Latest Release of CadencyDirect 07:00 HKT/SGT

ACN Search:

RSS

News Alerts


Home \| About us \| Services \| Partners \| Events \| Login \| Contact us \| Privacy Policy \| Terms of Use \| RSS

US: +1 214 890 4418 \| Beijing: +86 400 879 3881 \| Hong Kong: +852 8192 4922 \| Singapore: +65 6549 7068 \| Tokyo: +81 3 6859 8575

Connect With us: